AACR 2019:
March 29 – April 3 in Atlanta, GA
RSIP Vision participates in the AACR 2019 Annual Meeting. We are passionate about cancer research and will be happy to discuss your pharma projects with you. March 29 – April 3, 2019 in Atlanta, Georgia Contact Us
Read More
AI Pharma Innovation:
Feb 27-28 in S.Francisco, CA
RSIP Vision participates in the AI Pharma Innovation Drug Discovery 2019 event. Meet with us: we are passionate about AI in pharma projects and will be happy to discuss with you. February 27-28, 2019 in S.Francisco, CA Contact Us
Read More
Tissue Analysis with AI
RSIP Vision is introducing Deep Learning in the biopsy analysis procedure. Here is how the benefits of tissue analysis with AI have become available. Biopsy is the key examination used to determine the presence of most malignant tumors. Notwithstanding its importance and the need for millions of ...
Read More
Detection and Tracking of Tumors
RSIP Vision’s automated detection and tracking of tumors answers one of the most frequent needs in the pharma industry – assessment of patient response to a new drug. This very strong tool saves precious time in the clinical stage when the automated detection and tracking can supply the most accu...
Read More
Automated RECIST Measurement
RSIP Vision has develop an efficient tool for clinical trials in the pharma industry – the automated RECIST measurement. The gold standard in measuring the evolution of solid tumors, along the treatment with a tested drug, is the RECIST score (Response Evaluation Criteria in Solid Tumors), ...
Read More
Detection and Segmentation of Dendritic Cells
Dendritic cells are a type of antigen-presenting cells and have an integral part in the normal functioning immune system, in that they help to initiate primary immune response. Dendritic cells are typically present in tissues that come in contact with the external environment. That includes the s...
Read More
